Gene · 5339
Papers2,747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,747
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Methamphetamine induces transcriptional changes in cultured HIV-infected mature monocytes that may contribute to HIV neuropathogenesis. | Front Immunol | 2022 | 36059515 | PubTator, text mining | PubMed |
| Intestinal cellular heterogeneity and disease development revealed by single-cell technology. | Cell Regen | 2022 | 36045190 | PubTator, text mining | PubMed |
| CircCLTH promotes skeletal muscle development and regeneration. | Epigenetics | 2022 | 36043316 | PubTator, text mining | PubMed |
| CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | Oncogene | 2022 | 36042349 | PubTator, text mining | PubMed |
| Plectin promotes tumor formation by B16 mouse melanoma cells via regulation of Rous sarcoma oncogene activity. | BMC Cancer | 2022 | 36038818 | PubTator, text mining | PubMed |
| Case report: Identification of a novel heterozygous germline ERCC2 mutation in a patient with dermatofibrosarcoma protuberans. | Front Oncol | 2022 | 36033485 | PubTator, text mining | PubMed |
| Serological Investigation and Genetic Characteristics of Pseudorabies Virus between 2019 and 2021 in Henan Province of China. | Viruses | 2022 | 36016307 | PubTator, text mining | PubMed |
| Exosomes in Breast Cancer: Involvement in Tumor Dissemination and Prospects for Liquid Biopsy. | Int J Mol Sci | 2022 | 36012109 | PubTator, text mining | PubMed |
| Single-Cell and Bulk RNA Sequencing Reveal Malignant Epithelial Cell Heterogeneity and Prognosis Signatures in Gastric Carcinoma. | Cells | 2022 | 36010627 | PubTator, text mining | PubMed |
| Neurons: The Interplay between Cytoskeleton, Ion Channels/Transporters and Mitochondria. | Cells | 2022 | 36010576 | PubTator, text mining | PubMed |
| Inheritance of Monogenic Hereditary Skin Disease and Related Canine Breeds. | Vet Sci | 2022 | 36006348 | PubTator, text mining | PubMed |
| Cytoplasmic keratins couple with and maintain nuclear envelope integrity in colonic epithelial cells. | Mol Biol Cell | 2022 | 36001365 | PubTator, text mining | PubMed |
| Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma. | Front Oncol | 2022 | 35992814 | PubTator, text mining | PubMed |
| A Long-Circulating Vector for Aptamers Based upon Polyphosphodiester-Backboned Molecular Brushes. | Angew Chem Int Ed Engl | 2022 | 35979844 | PubTator, text mining | PubMed |
| DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. | Signal Transduct Target Ther | 2022 | 35973989 | PubTator, text mining | PubMed |
| Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening. | Front Immunol | 2022 | 35967298 | PubTator, text mining | PubMed |
| Occurrence of autoantibodies against skin proteins in patients with hereditary epidermolysis bullosa predisposes to development of autoimmune blistering disease. | Front Immunol | 2022 | 35958577 | PubTator, text mining | PubMed |
| Objective Evaluation of Clinical Actionability for Genes Involved in Myopathies: 63 Genes with a Medical Value for Patient Care. | Int J Mol Sci | 2022 | 35955641 | PubTator, text mining | PubMed |
| Aggregated Genomic Data as Cohort-Specific Allelic Frequencies can Boost Variants and Genes Prioritization in Non-Solved Cases of Inherited Retinal Dystrophies. | Int J Mol Sci | 2022 | 35955564 | PubTator, text mining | PubMed |
| Diagnostics of autoimmune blistering disorders: an experience of a single tertiary referral centre. | Postepy Dermatol Alergol | 2022 | 35950139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5339/papers?page=26